Atomoxetine Capsules Recalled for Chemical Impurity Above FDA Limits
Glenmark Pharmaceuticals is recalling 120,000 bottles of Atomoxetine 10 mg capsules nationwide due to N-nitroso Atomoxetine impurity exceeding FDA recommended limits. Multiple lot numbers are affected with expiration dates through July 2026.
- Product
- ATOMOXETINE — ATOMOXETINE (ATOMOXETINE)
- Category
- Drug
- Distribution
- Distributed nationwide